SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-07-30 |
| Reported value | $153,064,298 |
| Positions | 62 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| KRYSTAL BIOTECH INC | KRYS | COM | $16,725,150 | 45,000 |
| TG THERAPEUTICS INC | TGTX | COM | $13,791,314 | 251,025 |
| ABIVAX SA | ABVX | SPONSORED ADS | $12,926,220 | 97,000 |
| CHEVRON CORP | CVX | COM | $12,432,000 | 75,000 |
| EXXON MOBIL CORP | XOM | COM | $10,732,520 | 78,500 |
| ARROWHEAD PHARMACEUTICALS INC | ARWR | COM | $8,974,251 | 110,100 |
| VIKING THERAPEUTICS INC | VKTX | COM | $8,164,793 | 209,300 |
| CELCUITY INC | CELC | COM | $6,502,133 | 62,150 |
| NEKTAR THERAPEUTICS | NKTR | COM NEW | $6,234,033 | 89,300 |
| TESLA INC | TSLA | COM | $4,542,480 | 10,800 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.